Indian Drugs and Pharmaceuticals

Indian Drugs and Pharmaceuticals Limited (IDPL) is a public sector pharmaceutical, bulk drug manufacturing and drug discovery company owned by the Indian government, headquartered in New Delhi, and located in Hyderabad, Gurgaon and Rishikesh.:[1] The company is involved in patent development alongside, National Institute of Pharmaceutical Education and Research to provide affordable drugs, and has recently released three over the counter drugs.[2][3]

Indian Drugs and Pharmaceuticals Limited
TypePublic sector undertaking
Founded1961
HeadquartersNew Delhi
Hyderabad
Gurgaon
Rishikesh
ProductsDrugs and pharmaceuticals
WebsiteOfficial website

A new formulation unit was inaugurated in Hyderabad in February 2017.

Many attempts have been made to revive IDPL, declared sick by the Board for Industrial and Financial Reconstruction. The Government of India is exploring ways of strategically selling the unit and meet outstanding liabilities. On the 9th of February 2021, the Government of India announced the liquidation of IDPL.[4]

See also

References
  1. http://pharmaceuticals.gov.in/cpsu.pdf
  2. "IDPL Introduces Three New OTC Drugs - Pharmaceuticals & Healthcare Insight". Archived from the original on 24 March 2012. Retrieved 30 May 2011.
  3. "Department of Chemicals and Petrochemicals-Ministry of Chemicals and Fertilizers-Pharmaceuticals". Archived from the original on 11 June 2011. Retrieved 30 May 2011.
  4. "Govt has decided to shut 2 pharma PSUs, disinvest other 3: Govt tells LS". Business Standard India. Press Trust of India. 9 February 2021.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.